Yıl: 2022 Cilt: 23 Sayı: 2 Sayfa Aralığı: 106 - 110 Metin Dili: İngilizce DOI: 10.4274/jtgga.galenos.2021.2021-9-28 İndeks Tarihi: 16-06-2022

A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus

Öz:
Objective: We aimed to investigate maternal plasma endoplasmic reticulum to nucleus signalling-1 (ERN-1) concentrations in patients diagnosed with gestational diabetes mellitus (GDM). Material and Methods: This was a cross-sectional study of 57 pregnant women with GDM and 40 gestational age- and body mass indexmatched, healthy pregnant controls, conducted between August 2020 and November 2020. Plasma ERN-1 levels, other laboratory markers of insulin resistance, and demographic characteristics were compared between groups. Results: Fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), hemoglobin A1c and plasma ERN-1 levels were significantly higher in the GDM group than in the healthy controls (p<0.001). Positive correlation was found between ERN-1 levels and HOMA-IR values (p=0.016). The optimal cut-off value for ERN-1 to diagnose GDM was 6.960 ng/mL, with a sensitivity of 78.9% and a specificity of 75.0% (p<0.001). Conclusion: ERN-1 may be considered as a new marker for diagnosis of GDM and may also be a potential target in studies of GDM treatment modalities. (J Turk Ger Gynecol Assoc 2022; 23: 106-10)
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82.
  • 2. Oğlak SC, Obut M. Expression of ADAMTS13 and PCNA in the placentas of gestational diabetic mothers. Int J Morphol 2021; 39: 38-44.
  • 3. Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview. J Diabetes Res 2019; 2019: 5320156.
  • 4. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007; 50: 938-48.
  • 5. Lapolla A, Dalfrà MG, Mello G, Parretti E, Cioni R, Marzari C, et al. Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab 2008; 93: 876-80.
  • 6. Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care 2014; 37: 1590-6.
  • 7. Kim SY, Saraiva C, Curtis M, Wilson HG, Troyan J, Sharma AJ. Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009. Am J Public Health 2013; 103: e65-72.
  • 8. Bardenheier BH, Elixhauser A, Imperatore G, Devlin HM, Kuklina EV, Geiss LS, et al. Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care 2013; 36: 1209-14.
  • 9. Fadl HE, Ostlund IK, Magnuson AF, Hanson US. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 2010; 27: 436-41.
  • 10. Oğlak SC, Bademkıran MH, Obut M. Predictor variables in the success of slow-release dinoprostone used for cervical ripening in intrauterine growth restriction pregnancies. J Gynecol Obstet Hum Reprod 2020; 49: 101739.
  • 11. Oğlak SC, Tunç Ş, Obut M, Şeker E, Behram M, Tahaoğlu AE. Maternal near-miss patients and maternal mortality cases in a Turkish tertiary referral hospital. Ginekol Pol 2021; 92: 300-5.
  • 12. Burlina S, Dalfrà MG, Lapolla A. Short- and long-term consequences for offspring exposed to maternal diabetes: a review. J Matern Fetal Neonatal Med 2019; 32: 687-94.
  • 13. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007; 50: 752-63.
  • 14. Fonseca SG, Gromada J, Urano F. Endoplasmic reticulum stress and pancreatic β-cell death. Trends Endocrinol Metab 2011; 22: 266-74.
  • 15. Eizirik DL, Cnop M. ER stress in pancreatic beta cells: the thin red line between adaptation and failure. Sci Signal 2010; 3: pe7.
  • 16. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334: 1081-6.
  • 17. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519-29.
APA Süzen çaypınar S, BEHRAM M (2022). A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. , 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
Chicago Süzen çaypınar Sema,BEHRAM MUSTAFA A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. (2022): 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
MLA Süzen çaypınar Sema,BEHRAM MUSTAFA A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. , 2022, ss.106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
AMA Süzen çaypınar S,BEHRAM M A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. . 2022; 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
Vancouver Süzen çaypınar S,BEHRAM M A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. . 2022; 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
IEEE Süzen çaypınar S,BEHRAM M "A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus." , ss.106 - 110, 2022. 10.4274/jtgga.galenos.2021.2021-9-28
ISNAD Süzen çaypınar, Sema - BEHRAM, MUSTAFA. "A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus". (2022), 106-110. https://doi.org/10.4274/jtgga.galenos.2021.2021-9-28
APA Süzen çaypınar S, BEHRAM M (2022). A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. Journal of the Turkish-German Gynecological Association, 23(2), 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
Chicago Süzen çaypınar Sema,BEHRAM MUSTAFA A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. Journal of the Turkish-German Gynecological Association 23, no.2 (2022): 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
MLA Süzen çaypınar Sema,BEHRAM MUSTAFA A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. Journal of the Turkish-German Gynecological Association, vol.23, no.2, 2022, ss.106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
AMA Süzen çaypınar S,BEHRAM M A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. Journal of the Turkish-German Gynecological Association. 2022; 23(2): 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
Vancouver Süzen çaypınar S,BEHRAM M A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus. Journal of the Turkish-German Gynecological Association. 2022; 23(2): 106 - 110. 10.4274/jtgga.galenos.2021.2021-9-28
IEEE Süzen çaypınar S,BEHRAM M "A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus." Journal of the Turkish-German Gynecological Association, 23, ss.106 - 110, 2022. 10.4274/jtgga.galenos.2021.2021-9-28
ISNAD Süzen çaypınar, Sema - BEHRAM, MUSTAFA. "A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus". Journal of the Turkish-German Gynecological Association 23/2 (2022), 106-110. https://doi.org/10.4274/jtgga.galenos.2021.2021-9-28